When a medical device manufacturer executes a lease or breaks ground on a strategically selected facility, it builds a foundation for optimal performance. Real estate and income tax breaks and location-specific business incentives also factor into performance. The weight given to location strategy and site selection components varies by company. A prospective location may offer tax incentives that would significantly reduce production costs. But if it’s on the other end of the globe from distribution centers and major customers, those incentives likely won’t offset supply chain and logistics costs. Companies that want to reshore or nearshore operations to reduce supply chain risk, support a just-in-time inventory strategy and gain greater proximity to healthcare customers would need to balance higher location costs against the benefits of reshoring.

Now that you’ve identified and balanced your priorities, download an infographic to consider two hypothetical journeys that impact how and when you get devices and technologies to healthcare providers faster.